Abstract:Loss of function mutations in the X-linked gene encoding methyl-CpG binding protein 2 (MECP2) cause Rett syndrome (RTT), a postnatal neurological disorder. The loss of motor function is an important clinical feature of RTT that manifests early during the course of the disease. RTT mouse models with mutations in the murine orthologous Mecp2 gene replicate many human phenotypes, including progressive motor impairments. However, relatively little is known about the changes in circuit function during the progression of motor deficit in this model. As the motor cortex is the key node in the motor system for the control of voluntary movement, we measured firing activity in populations of motor cortical neurons during locomotion on a motorized wheel-treadmill. Different populations of neurons intermingled in the motor cortex signal different aspects of the locomotor state of the animal. The proportion of running selective neurons whose activity positively correlates with locomotion speed gradually decreases with weekly training in wild-type mice, but not in Mecp2-null mice. The fraction of rest-selective neurons whose activity negatively correlates with locomotion speed does not change with training in wild-type mice, but is higher and increases with the progression of locomotion deficit in mutant mice. The synchronization of population activity that occurs in WT mice with training did not occur in Mecp2-null mice, a phenotype most clear during locomotion and observable across all functional cell types. Our results could represent circuit-level biomarkers for motor regression in Rett syndrome.

Dysregulated Cortical Synaptic Plasticity under Methyl-Cpg Binding Protein 2 Deficiency and Its Implication in Motor Impairments

Downregulation of CNPase in a MeCP2 Deficient Mouse Model of Rett Syndrome.

Selective Preservation of Cholinergic Mecp2 Rescues Specific Rett-Syndrome-Like Phenotypes in Mecp2(Stop) Mice

MeCP2 Deficiency Impairs Motor Cortical Circuit Flexibility Associated with Motor Learning

MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome.

Regulation Mechanism and Research Progress of MeCP2 in Rett Syndrome

Global Impairment of Immediate-Early Genes Expression in Rett Syndrome Models and Patients Linked to Myelination Defects

Mecp2 Regulates The Timing Of Critical Period Plasticity That Shapes Functional Connectivity In Primary Visual Cortex

A Partial Loss of Function Allele of Methyl-Cpg-binding Protein 2 Predicts a Human Neurodevelopmental Syndrome.

Manipulations of MeCP2 in Glutamatergic Neurons Highlight Their Contributions to Rett and Other Neurological Disorders.

Rett Syndrome Linked to Defects in Forming the MeCP2/Rbfox/LASR Complex in Mouse Models

Loss and Gain of MeCP2 Cause Similar Hippocampal Circuit Dysfunction That is Rescued by Deep Brain Stimulation in a Rett Syndrome Mouse Model.

Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials

Motor Training Improves Coordination and Anxiety in Symptomaticmecp2-Null Mice Despite Impaired Functional Connectivity Within the Motor Circuit

Research Progress of Rett Syndrome Causing Gene MECP2-The Structure, Function and Modulation of MECP2

Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2

Early differential impact of MeCP2 mutations on functional networks in Rett syndrome patient-derived human cerebral organoids

MeCP2 and neurodevelopmental disorders

MeCP2 co-ordinates liver lipid metabolism with the NCoR1/HDAC3 corepressor complex

Loss of O-GlcNAcylation on MeCP2 at Threonine 203 Leads to Neurodevelopmental Disorders

A novel pathogenic mutation of MeCP2 impairs chromatin association independent of protein levels